Coated Component for Medicinal Delivery Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Medicinal delivery devices, particularly inhalers, face variability in dosing due to undesirable interactions between device components and medicinal formulations, leading to issues like medicament degradation and permeation of ambient water, which affect the consistency and reliability of drug delivery.
Innovation Solution
A coated component for medicinal delivery devices featuring a fluorine-containing coating with two layers: a polyfluoropolyether-containing layer and a non-fluorinated layer, applied using a silane-based primer and coating composition, which reduces surface energy and minimizes interactions with the medicinal formulation, thereby enhancing consistency and reducing variability in dosing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If a component material with desirable bulk properties is selected, then mechanical strength and other bulk properties are improved, but surface properties such as surface energy may be unsuitable leading to undesirable interactions with medicinal formulation
Solution Approach 1:
The patent applies a coating to the surface of the component to provide locally different properties from the bulk material. The coating layer has low surface energy and minimal interaction with medicinal formulation, while the bulk material maintains its mechanical strength and structural integrity. This resolves the contradiction by having different parts of the component (surface vs bulk) serve different functions.
Solution Approach 2:
The patent creates a composite structure consisting of the base component material combined with a surface coating layer. The coating comprises fluorinated compounds that provide desirable surface properties (low surface energy, minimal permeation, minimal adsorption) while the substrate provides mechanical strength. This composite approach allows both bulk strength and surface compatibility to be optimized simultaneously.
2Use of energy by moving object
If materials with high surface energy are used for certain components, then adhesion properties are improved, but operation of movable components may be adversely affected
Solution Approach 1:
The coating is applied selectively to surfaces where low adhesion is desirable for movable components, while allowing high adhesion elsewhere if needed. The fluorinated coating reduces surface energy specifically at interfaces where material buildup or sticking would impede movement, resolving the contradiction between adhesion and ease of operation.
3Device complexity
If ambient water permeation is not prevented, then device simplicity is maintained, but medicament degradation and dosing variability occur
Solution Approach 1:
The patent applies a thin film coating to the component surface that acts as a barrier to water permeation. This coating is sufficiently thin and lightweight that it does not significantly increase device complexity, while effectively preventing ambient water from penetrating into the medicinal formulation, thereby maintaining dosing consistency and preventing medicament degradation.
Solution Approach 2:
The fluorinated coating changes the surface properties of the component, specifically reducing surface energy and creating a hydrophobic barrier. This parameter change prevents water permeation without requiring additional structural components, maintaining device simplicity while improving reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The coated component significantly reduces dose-to-dose and unit-to-unit variability in medicinal delivery devices, improving the consistency and reliability of drug delivery by minimizing medicament deposition on device surfaces and maintaining the integrity of the formulation.
Implementation Method 1
reduces surface energy and minimizes interactions with the medicinal formulation
Implementation Method 2
minimizes interactions with the medicinal formulation, thereby enhancing consistency and reducing variability in dosing
Data Source
Figure 1a
Figure 1b
Figure 2a~2b
AI summary
Methods of making components for a medicinal delivery device are described, in which a primer composition comprising a silane having two or more reactive silane groups separated by an organic linker group is applied to a surface of a component, then a coating composition comprising an at least partially fluorinated compound is applied to the primed surface. The surface may be a polymer surface. Corresponding coated components and a medicinal delivery device are disclosed. Methods of making metal components are described in which a coating composition comprising an at least partially fluorinated compound is applied to a surface cleaned with a solvent.